Gene: AVPR1A

552
AVPR V1a|AVPR1|V1aR
arginine vasopressin receptor 1A
protein-coding
12q14.2
Ensembl:ENSG00000166148 MIM:600821 Vega:OTTHUMG00000169980 UniprotKB:P37288
NC_000012.12
PubMed
0   ANCO-SNPs
OD
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
9.827e-1 (AD)  8.133e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
SVIL0.656
PCDH180.597
THBD0.596
RBM460.579
ITGB30.57
IL60.55
CD930.549
MALL0.547
THBS10.546
PDE3A0.544

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
RBM34-0.358
UCN-0.348
UBAP1L-0.335
CHST8-0.311
RS1-0.308
CRYGS-0.308
TMEM191C-0.303
LY6H-0.299
BAIAP2L2-0.297
FTCD-0.291

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB00035DesmopressinSmall Molecule16679-58-6ApprovedTarget
DB00067VasopressinSmall Molecule11000-17-2ApprovedTarget
DB00093FelypressinSmall Molecule56-59-7ApprovedTarget
DB00872ConivaptanSmall Molecule210101-16-9Approved|InvestigationalTarget
DB02638TerlipressinSmall Molecule14636-12-5Approved|InvestigationalTarget
DB05452PH-284Small Molecule-InvestigationalTarget
DB06212TolvaptanSmall Molecule150683-30-0ApprovedTarget
DB13929RelcovaptanSmall Molecule150375-75-0InvestigationalTarget
ID Drug Name Action PubMed
C0264861,2,5,6-dibenzanthracene"1,2,5,6-dibenzanthracene results in decreased expression of AVPR1A mRNA"26377693
C0493251,2-dithiol-3-thione"1,2-dithiol-3-thione results in decreased expression of AVPR1A mRNA"19162173
C0317631,3-butadiene"1,3-butadiene results in decreased expression of AVPR1A mRNA"21147608
C0284741,4-bis(2-(3,5-dichloropyridyloxy))benzene"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in decreased expression of AVPR1A mRNA"28903501
C0291412,2,5,7,8-pentamethyl-1-hydroxychroman"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of AVPR1A mRNA"21920950
C0164032,4-dinitrotoluene"2,4-dinitrotoluene affects the expression of AVPR1A mRNA"21346803
C1079462,7-dihydroxynaphthalene"2,7-dihydroxynaphthalene results in decreased expression of AVPR1A mRNA"28940058
C5850042-monochloropropanediol2-monochloropropanediol results in increased expression of AVPR1A mRNA28522335
C0293704-toluidine4-toluidine results in decreased expression of AVPR1A mRNA27638505
D000082AcetaminophenAcetaminophen affects the expression of AVPR1A mRNA17562736
D000082AcetaminophenAcetaminophen results in decreased expression of AVPR1A mRNA17202762
C560978aegeline[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of AVPR1A mRNA28843594
D016604Aflatoxin B1Aflatoxin B1 results in decreased methylation of AVPR1A gene27153756
D016604Aflatoxin B1Aflatoxin B1 results in decreased expression of AVPR1A mRNA19770486
D000517alpha-Chlorohydrinalpha-Chlorohydrin results in increased expression of AVPR1A mRNA28522335
D000643Ammonium ChlorideAmmonium Chloride affects the expression of AVPR1A mRNA16483693
D000661AmphetamineAmphetamine results in increased expression of AVPR1A protein19858480
C032739aroclor 1221aroclor 1221 results in decreased expression of AVPR1A mRNA26620572
C015001arsenitearsenite results in increased methylation of AVPR1A promoter23974009
C030935benz(a)anthracenebenz(a)anthracene results in decreased expression of AVPR1A mRNA26377693
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of AVPR1A mRNA19770486|2222880
C006780bisphenol Abisphenol A affects the expression of AVPR1A mRNA29097150
C006780bisphenol Abisphenol A results in decreased expression of AVPR1A mRNA25181051
D001761BleomycinBleomycin results in decreased expression of AVPR1A mRNA15808516
D002110Caffeine[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of AVPR1A mRNA28843594
D002118Calcium[AVP binds to and results in increased activity of AVPR1A protein] which results in increased abundance of Calcium11553362
D002118Calcium[[AVP binds to and results in increased activity of AVPR1A protein] which results in increased abundance of Calcium] which results in increased activity of CHRM1 protein11553362
D002118Calcium[[[AVP binds to and results in increased activity of AVPR1A protein] which results in increased abundance of Calcium] which results in increased activity of CHRM1 protein] which results in decreased susceptibility to Scopolamine Hydrobromide11553362
D002118CalciumCarbachol promotes the reaction [[NC 1900 results in increased activity of AVPR1A protein] which results in increased abundance of Calcium]12646291
D002118Calcium[NC 1900 results in increased activity of AVPR1A protein] which results in increased abundance of Calcium12646291
D002118CalciumNicardipine inhibits the reaction [Carbachol promotes the reaction [[NC 1900 results in increased activity of AVPR1A protein] which results in increased abundance of Calcium]]12646291
D002118CalciumNicardipine inhibits the reaction [[NC 1900 results in increased activity of AVPR1A protein] which results in increased abundance of Calcium]12646291
D002217CarbacholCarbachol promotes the reaction [[NC 1900 results in increased activity of AVPR1A protein] which results in increased abundance of Calcium]12646291
D002217CarbacholNicardipine inhibits the reaction [Carbachol promotes the reaction [[NC 1900 results in increased activity of AVPR1A protein] which results in increased abundance of Calcium]]12646291
D002251Carbon TetrachlorideCarbon Tetrachloride results in decreased expression of AVPR1A mRNA27339419
D002330CarmustineCarmustine results in increased expression of AVPR1A mRNA15980968
C054133casticincasticin results in decreased expression of AVPR1A mRNA28444820
D004390ChlorpyrifosChlorpyrifos results in increased expression of AVPR1A mRNA25889763
D004390ChlorpyrifosChlorpyrifos results in decreased expression of AVPR1A mRNA20682304
D002994ClofibrateClofibrate results in decreased expression of AVPR1A mRNA23811191
D002995Clofibric AcidClofibric Acid affects the expression of AVPR1A mRNA17602206
C004690coclaurine[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of AVPR1A mRNA28843594
C030123coumarincoumarin results in decreased expression of AVPR1A mRNA18480146
D003471CuprizoneCuprizone results in increased expression of AVPR1A mRNA26577399
D003513CycloheximideCycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of AVPR1A mRNA]11007951
D016572CyclosporineCyclosporine results in increased expression of AVPR1A mRNA19770486
D003993Dibutyl PhthalateDibutyl Phthalate results in decreased expression of AVPR1A mRNA21266533
D003993Dibutyl PhthalateDibutyl Phthalate results in increased expression of AVPR1A mRNA21266533
D004041Dietary FatsDietary Fats results in decreased expression of AVPR1A mRNA22609946
D004051Diethylhexyl PhthalateDiethylhexyl Phthalate results in decreased expression of AVPR1A mRNA19850644
D004051Diethylhexyl PhthalatePPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of AVPR1A mRNA]19850644
D004051Diethylhexyl PhthalateDiethylhexyl Phthalate results in decreased expression of AVPR1A mRNA28871463
D004052Diethylnitrosamine[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of AVPR1A mRNA24535843
D004052DiethylnitrosamineDiethylnitrosamine results in decreased expression of AVPR1A mRNA24535843
D004052Diethylnitrosamine[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of AVPR1A mRNA28943392
D004052DiethylnitrosamineDiethylnitrosamine results in decreased expression of AVPR1A mRNA19638242
C015835dimethyl-4-toluidinedimethyl-4-toluidine results in decreased expression of AVPR1A mRNA27638505
D004317DoxorubicinDoxorubicin results in increased expression of AVPR1A mRNA28940058
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of AVPR1A mRNA15953391|1710823
C024565ethylene dichlorideethylene dichloride results in increased expression of AVPR1A mRNA28189721
D005038EthylnitrosoureaEthylnitrosourea results in increased mutagenesis of AVPR1A gene16495775
C110660F-180 vasoconstrictor peptideF-180 vasoconstrictor peptide affects the activity of AVPR1A protein21688787
D005485FlutamideFlutamide results in decreased expression of AVPR1A mRNA24136188
C039281furanfuran results in decreased expression of AVPR1A mRNA25539665
C012348higenamine[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of AVPR1A mRNA28843594
D017313FenretinideFenretinide results in increased expression of AVPR1A mRNA28973697
D047348Hydrolyzable Tannins[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of AVPR1A mRNA28843594
D01979615-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid"[AVP protein binds to and results in increased activity of AVPR1A protein] which results in decreased activity of 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid"1399968
D01979615-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid"[Vasotocin analog binds to and results in decreased activity of AVPR1A protein] inhibits the reaction [[AVP protein binds to and results in decreased activity of AVPR1A protein] which results in decreased activity of 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid]"1399968
D01979615-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid"[Vasotocin analog binds to and results in decreased activity of AVPR1A protein] inhibits the reaction [OXT protein affects the activity of 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid]"1399968
C016517indole-3-carbinolindole-3-carbinol affects the expression of AVPR1A mRNA21396975
D014668VasotocinVasotocin analog binds to and results in decreased activity of AVPR1A protein1399968
D014668Vasotocin"[Vasotocin analog binds to and results in decreased activity of AVPR1A protein] inhibits the reaction [[AVP protein binds to and results in decreased activity of AVPR1A protein] which results in decreased activity of 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid]"1399968
D014668Vasotocin"[Vasotocin analog binds to and results in decreased activity of AVPR1A protein] inhibits the reaction [OXT protein affects the activity of 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid]"1399968
C045463leflunomideleflunomide results in increased expression of AVPR1A mRNA24136188
D008727MethotrexateMethotrexate affects the expression of AVPR1A mRNA18502557
C445068methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate"methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in decreased activity of AVPR1A protein"28790194
D008997MonobactamsMonobactams analog binds to AVPR1A protein16504276
D009020MorphineMorphine results in decreased expression of AVPR1A mRNA21178816
C500085muraglitazarmuraglitazar results in decreased expression of AVPR1A mRNA21515302
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of AVPR1A mRNA"25554681|2562005
C017096n-butoxyethanoln-butoxyethanol results in decreased expression of AVPR1A mRNA19812364
C115056NC 1900Carbachol promotes the reaction [[NC 1900 results in increased activity of AVPR1A protein] which results in increased abundance of Calcium]12646291
C115056NC 1900NC 1900 results in increased activity of AVPR1A protein12646291
C115056NC 1900[NC 1900 results in increased activity of AVPR1A protein] which results in increased abundance of Calcium12646291
C115056NC 1900Nicardipine inhibits the reaction [Carbachol promotes the reaction [[NC 1900 results in increased activity of AVPR1A protein] which results in increased abundance of Calcium]]12646291
C115056NC 1900Nicardipine inhibits the reaction [[NC 1900 results in increased activity of AVPR1A protein] which results in increased abundance of Calcium]12646291
C051752nefazodonenefazodone results in decreased expression of AVPR1A mRNA24136188
D009529NicardipineNicardipine inhibits the reaction [Carbachol promotes the reaction [[NC 1900 results in increased activity of AVPR1A protein] which results in increased abundance of Calcium]]12646291
D009529NicardipineNicardipine inhibits the reaction [[NC 1900 results in increased activity of AVPR1A protein] which results in increased abundance of Calcium]12646291
C012655nimesulidenimesulide results in decreased expression of AVPR1A mRNA24136188
C002741N-nitrosomorpholineN-nitrosomorpholine results in decreased expression of AVPR1A mRNA19716841
C572573N-nitroso-tris-chloroethylurea[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of AVPR1A mRNA27935865
C572573N-nitroso-tris-chloroethylurea[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AVPR1A mRNA27935865
D010100OxygenOxygen deficiency results in increased activity of AVPR1A protein20708107
D010126Ozone[Ozone co-treated with NOTCH4 gene mutant form] affects the expression of AVPR1A mRNA25658374
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in decreased expression of AVPR1A mRNA19162173
C023036perfluorooctanoic acidperfluorooctanoic acid results in decreased expression of AVPR1A mRNA19162173
D010634Phenobarbital[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of AVPR1A mRNA24535843
D010634PhenobarbitalNR1I3 protein affects the reaction [Phenobarbital results in increased expression of AVPR1A mRNA]19482888
D010634PhenobarbitalPhenobarbital affects the expression of AVPR1A mRNA23091169
D010634PhenobarbitalPhenobarbital results in decreased expression of AVPR1A mRNA19270015
D010634PhenobarbitalPhenobarbital results in increased expression of AVPR1A mRNA19482888
D010634PhenobarbitalPhenobarbital results in decreased expression of AVPR1A mRNA19162173
C060836pioglitazone[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of AVPR1A mRNA27935865
D010890PirenzepinePirenzepine binds to and results in decreased activity of AVPR1A protein11553362
C006253pirinixic acid[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of AVPR1A mRNA19710929
C006253pirinixic acidpirinixic acid results in decreased expression of AVPR1A mRNA17950772|2081375
C006253pirinixic acidpirinixic acid results in decreased expression of AVPR1A mRNA19162173
D059808PolyphenolsPolyphenols results in decreased expression of AVPR1A mRNA16293270
D011285Pregnenolone CarbonitrilePregnenolone Carbonitrile results in decreased expression of AVPR1A mRNA19162173
D011374ProgesteroneProgesterone results in increased expression of AVPR1A mRNA20864642
D011374ProgesteroneProgesterone results in increased expression of AVPR1A mRNA22238285
C082134relcovaptanrelcovaptan results in decreased activity of AVPR1A protein15685210
C082134relcovaptanrelcovaptan binds to and results in decreased activity of AVPR1A protein10440088|1067950
D012312RitodrineRitodrine results in decreased expression of AVPR1A mRNA23370008
C089730rosiglitazonerosiglitazone results in decreased expression of AVPR1A mRNA21515302
D012601Scopolamine Hydrobromide[[[AVP binds to and results in increased activity of AVPR1A protein] which results in increased abundance of Calcium] which results in increased activity of CHRM1 protein] which results in decreased susceptibility to Scopolamine Hydrobromide11553362
C009250sevofluranesevoflurane affects the expression of AVPR1A mRNA15967596
C009277sodium arsenatesodium arsenate results in increased expression of AVPR1A mRNA21795629
D013629TamoxifenTamoxifen affects the expression of AVPR1A mRNA20937368
D013749TetrachlorodibenzodioxinCycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of AVPR1A mRNA]11007951
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of AVPR1A mRNA11007951
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of AVPR1A mRNA26377647
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of AVPR1A mRNA19770486|2629044
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of AVPR1A mRNA22298810
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of AVPR1A mRNA21724226
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of AVPR1A mRNA16054898|2121527
D013853Thioacetamide[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of AVPR1A mRNA28943392
D013853ThioacetamideThioacetamide results in decreased expression of AVPR1A mRNA16337175|2341159
C009495titanium dioxidetitanium dioxide results in decreased expression of AVPR1A mRNA27760801
D014028Tobacco Smoke PollutionTobacco Smoke Pollution affects the expression of AVPR1A mRNA20133372
C052342topiramatetopiramate results in decreased expression of AVPR1A mRNA16979414
C015559trimellitic anhydridetrimellitic anhydride results in increased expression of AVPR1A mRNA19042947
C057693troglitazonetroglitazone results in decreased expression of AVPR1A mRNA21515302
C406224valdecoxibvaldecoxib results in decreased expression of AVPR1A mRNA24136188
D014635Valproic AcidValproic Acid results in increased expression of AVPR1A mRNA28001369
D014635Valproic AcidValproic Acid affects the expression of AVPR1A mRNA17292431|1796380
D014640VancomycinVancomycin results in increased expression of AVPR1A mRNA18930951
C025043vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine-"vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine- binds to and results in decreased activity of AVPR1A protein"8017639
C559490vasopressin, Phe(2)-Ile(3)-Hgn(4)-Orn(iPr)(8)-"vasopressin, Phe(2)-Ile(3)-Hgn(4)-Orn(iPr)(8)- binds to and results in increased activity of AVPR1A protein"21688787
D001335Vehicle EmissionsVehicle Emissions affects the methylation of AVPR1A gene25560391
C029297vinylidene chloridevinylidene chloride results in decreased expression of AVPR1A mRNA26682919
D014874Water Pollutants, Chemical"Water Pollutants, Chemical results in decreased expression of AVPR1A mRNA"24525044
C581157XL147[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AVPR1A mRNA27935865
D015016Yohimbine[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of AVPR1A mRNA28843594

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0004930G-protein coupled receptor activity-IBA21873635  
GO:0005000vasopressin receptor activity-IBA21873635  
GO:0005080protein kinase C binding-TAS10858434  
GO:0005515protein binding-IPI18402937  
GO:0017046peptide hormone binding-IEA-  
GO:0031894V1A vasopressin receptor binding-IEA-  
GO:0042277peptide binding-IBA21873635  
GO ID GO Term Qualifier Evidence PubMed
GO:0001992regulation of systemic arterial blood pressure by vasopressin-IBA21873635  
GO:0002125maternal aggressive behavior-IEA-  
GO:0003084positive regulation of systemic arterial blood pressure-IEA-  
GO:0006091generation of precursor metabolites and energy-TAS8106369  
GO:0007186G-protein coupled receptor signaling pathway-IBA21873635  
GO:0007186G-protein coupled receptor signaling pathway-TAS-  
GO:0007202activation of phospholipase C activity-TAS8106369  
GO:0007204positive regulation of cytosolic calcium ion concentration-IEA-  
GO:0007621negative regulation of female receptivity-IEA-  
GO:0007625grooming behavior-IEA-  
GO:0008015blood circulation-TAS8106369  
GO:0008284positive regulation of cell proliferation-IEA-  
GO:0010460positive regulation of heart rate-IEA-  
GO:0014049positive regulation of glutamate secretion-IEA-  
GO:0014902myotube differentiation-IEA-  
GO:0019722calcium-mediated signaling-IEA-  
GO:0021537telencephalon development-IEA-  
GO:0030307positive regulation of cell growth-IEA-  
GO:0031394positive regulation of prostaglandin biosynthetic process-IEA-  
GO:0032849positive regulation of cellular pH reduction-IEA-  
GO:0032870cellular response to hormone stimulus-IBA21873635  
GO:0035176social behavior-IEA-  
GO:0035815positive regulation of renal sodium excretion-IEA-  
GO:0042631cellular response to water deprivation-IEA-  
GO:0042711maternal behavior-IBA21873635  
GO:0042713sperm ejaculation-IEA-  
GO:0043084penile erection-IEA-  
GO:0045907positive regulation of vasoconstriction-IBA21873635  
GO:0051412response to corticosterone-IEA-  
GO:0051970negative regulation of transmission of nerve impulse-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005768endosome-TAS10858434  
GO:0005886plasma membrane-TAS-  
GO:0005887integral component of plasma membrane-IBA21873635  
GO:0005887integral component of plasma membrane-TAS8838314  
KEGG ID KEGG Term
hsa04020Calcium signaling pathway
hsa04080Neuroactive ligand-receptor interaction
hsa04270Vascular smooth muscle contraction
Reactome ID Reactome Term Evidence
R-HSA-162582Signal TransductionTAS
R-HSA-1643685DiseaseTAS
R-HSA-372790Signaling by GPCRTAS
R-HSA-373076Class A/1 (Rhodopsin-like receptors)TAS
R-HSA-375276Peptide ligand-binding receptorsTAS
R-HSA-388396GPCR downstream signallingTAS
R-HSA-388479Vasopressin-like receptorsTAS
R-HSA-416476G alpha (q) signalling eventsTAS
R-HSA-500792GPCR ligand bindingTAS
R-HSA-5619099Defective AVP causes neurohypophyseal diabetes insipidus (NDI)TAS
R-HSA-5619102SLC transporter disordersTAS
R-HSA-5619115Disorders of transmembrane transportersTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
24845178Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotype. (2014 Jul)Levran OPsychoneuroendocrinology